1. Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first‐line intensified treatment of pediatric patients with high‐risk acute lymphoblastic leukemia in CoALL08‐09 trial. Issue 12 (21st September 2022) Authors: Mezger, Kerstin; Ebert, Sabine; Muhle, Hannah Elisa; Stadt, Udo zur; Borkhardt, Arndt; Dilloo, Dagmar; Faber, Jörg; Feuchtinger, Tobias; Imschweiler, Thomas; Jorch, Norbert; Pekrun, Arnulf; Schmid, Irene; Schramm, Franziska; Zimmermann, Martin; Horstmann, Martin A; Escherich, Gabriele Journal: Pediatric blood & cancer Issue: Volume 69:Issue 12(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL. (31st December 2023) Authors: Ziegler, Nicole; Cortés-López, Mariela; Alt, Francesca; Sprang, Maximilian; Ustjanzew, Arsenij; Lehmann, Nadine; El Malki, Khalifa; Wingerter, Arthur; Russo, Alexandra; Beck, Olaf; Attig, Sebastian; Roth, Lea; König, Julian; Paret, Claudia; Faber, Jörg Journal: Oncoimmunology Issue: Volume 12:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Apoptosis of ileal crypt epithelia after allogeneic bone marrow transplantation without graft‐versus‐host disease. Issue 5 (19th February 2015) Authors: Kreft, Andreas; Russo, Alexandra; Lux, Steffi; Waiz, Lioudmila; Seidmann, Larissa; Faber, Jörg; Kirkpatrick, Charles J. Journal: Clinical case reports Issue: Volume 3:Issue 5(2015:Oct.) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis. Issue 5 (June 2017) Authors: Fischer, Jeannette; Paret, Claudia; El Malki, Khalifa; Alt, Francesca; Wingerter, Arthur; Neu, Marie A.; Kron, Bettina; Russo, Alexandra; Lehmann, Nadine; Roth, Lea; Fehr, Eva-M.; Attig, Sebastian; Hohberger, Alexander; Kindler, Thomas; Faber, Jörg Journal: Journal of immunotherapy Issue: Volume 40:Issue 5(2017:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features. (11th November 2018) Authors: Andreiuolo, Felipe; Varlet, Pascale; Tauziède‐Espariat, Arnault; Jünger, Stephanie T.; Dörner, Evelyn; Dreschmann, Verena; Kuchelmeister, Klaus; Waha, Andreas; Haberler, Christine; Slavc, Irene; Corbacioglu, Selim; Riemenschneider, Markus J.; Leipold, Alfred; Rüdiger, Thomas; Körholz, Dieter; Ack... Journal: Brain pathology Issue: Volume 29:Number 2(2019) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Daunorubicin during delayed intensification decreases the incidence of infectious complications – a randomized comparison in trial CoALL 08-09. Issue 1 (2nd January 2019) Authors: Schramm, Franziska; Zimmermann, Martin; Jorch, Norbert; Pekrun, Arnulf; Borkhardt, Arndt; Imschweiler, Thomas; Christiansen, Holger; Faber, Jörg; Feuchtinger, Tobias; Schmid, Irene; Beron, Gerhard; Horstmann, Martin A.; Escherich, Gabriele Journal: Leukemia & lymphoma Issue: Volume 60:Issue 1(2019) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DIPG-43. Glucosylceramide synthase inhibitors induce ceramide accumulation and sensitise H3K27 Mutant Diffuse midline Glioma to irradiation. (3rd June 2022) Authors: Paret, Claudia; Sandhoff, Roger; Zahnreich, Sebastian; Wehling, Pia Charlotte; El Malki, Khalifa; Faber, Jörg Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EPEN-29. INDIVIDUALIZED THERAPY OF AN ANAPLASTIC EPENDYMOMA PEDIATRIC PATIENT WITH A NOTCH1 GERMLINE MUTATION. Issue 2 (22nd June 2018) Authors: Russo, Alexandra; Paret, Claudia; Lehmann, Nadine; Bender, Hannah; Wingerter, Arthur; Neu, Marie Astrid; Alt, Francesca; Backes, Nora; Roth, Lea; Seidmann, Larissa; Faber, Jörg Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Feedback from the fourth European Bioanalysis Forum Young Scientist Symposium. (23rd October 2018) Authors: Velghe, Sofie; Mercolini, Laura; McDonagh, Ryan; Maguire, Cara; Mahammed, Farjana; Lucey, Richard; Kahnt, Ariane; Hlatshwayo, Godknows; Faber, Jörg; Timmerman, Philip Journal: Bioanalysis Issue: Volume 10:Number 20(2018) Page Start: 1631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. First experience of the AML‐Berlin‐Frankfurt‐Münster group in pediatric patients with standard‐risk acute promyelocytic leukemia treated with arsenic trioxide and all‐trans retinoid acid. Issue 8 (23rd January 2017) Authors: Creutzig, Ursula; Dworzak, Michael N.; Bochennek, Konrad; Faber, Jörg; Flotho, Christian; Graf, Norbert; Kontny, Udo; Rossig, Claudia; Schmid, Irene; von Stackelberg, Arend; Mueller, Jans‐Enno; von Neuhoff, Christine; Reinhardt, Dirk; von Neuhoff, Nils Journal: Pediatric blood & cancer Issue: Volume 64:Issue 8(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗